Joachim Alexandre

6PUBLICATIONS
27CO-AUTHORS
HaematologyCardiology (incl. cardiovascular diseases)AutoimmunityImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 07, 2026
Bruton's tyrosine kinase inhibitors and cardiovascular risk: a meta-analysis.

|Sep 27, 2025
Association Between the Renin-Angiotensin System and Ibrutinib-Related Cardiovascular Adverse Events: A Translational Cohort Study.

Jonaz Font, Amir Hodzic, Angélique Da-Silva

|Jun 26, 2025
Immune checkpoint inhibitor-associated myocarditis: a novel risk score.

John R Power, Charles Dolladille, Benay Ozbay

|Sep 19, 2024
Is ibrutinib-related atrial fibrillation dose dependent? Insights from an individual case level analysis of the World Health Organization pharmacovigilance database.

Joachim Alexandre, Jonaz Font, Da-Silva Angélique

|Sep 16, 2021
Cardiovascular immunotoxicities associated with immune checkpoint inhibitors: a safety meta-analysis.

Charles Dolladille, Julia Akroun, Pierre-Marie Morice

Pageof 1

Frequent Collaborators

4 joint publications

Charles Dolladille

4 joint publications

Damien Legallois

2 joint publications

Jennifer Cautela

2 joint publications

Jonaz Font